CN106421165A - 一种治疗外阴瘙痒的中药组合物及其制备方法 - Google Patents
一种治疗外阴瘙痒的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN106421165A CN106421165A CN201610944759.4A CN201610944759A CN106421165A CN 106421165 A CN106421165 A CN 106421165A CN 201610944759 A CN201610944759 A CN 201610944759A CN 106421165 A CN106421165 A CN 106421165A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- active component
- extract
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 208000008350 Pruritus Vulvae Diseases 0.000 title abstract description 7
- 206010056530 Vulvovaginal pruritus Diseases 0.000 title abstract description 7
- 241001252601 Blumea Species 0.000 claims abstract description 17
- 244000103090 Eucalyptus robusta Species 0.000 claims abstract description 17
- 235000005221 swamp mahogany Nutrition 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 49
- 239000000463 material Substances 0.000 claims description 38
- 208000003251 Pruritus Diseases 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000000706 filtrate Substances 0.000 claims description 18
- 241000218691 Cupressaceae Species 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 9
- -1 filtration Substances 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 2
- 240000006550 Lantana camara Species 0.000 abstract 1
- 244000228293 Persicaria perfoliata Species 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 11
- 201000005630 leukorrhea Diseases 0.000 description 9
- 206010046901 vaginal discharge Diseases 0.000 description 9
- 201000004624 Dermatitis Diseases 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000006188 syrup Substances 0.000 description 8
- 235000020357 syrup Nutrition 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000001139 anti-pruritic effect Effects 0.000 description 4
- 239000003908 antipruritic agent Substances 0.000 description 4
- 230000003467 diminishing effect Effects 0.000 description 4
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000004334 sorbic acid Substances 0.000 description 4
- 235000010199 sorbic acid Nutrition 0.000 description 4
- 229940075582 sorbic acid Drugs 0.000 description 4
- 210000003905 vulva Anatomy 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- 240000000572 Blumea balsamifera Species 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Chemical class 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000001913 cellulose Chemical class 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Chemical class 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 201000002266 mite infestation Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 229920001223 polyethylene glycol Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000006353 Filariasis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 108010010803 Gelatin Chemical class 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000075898 Lantana strigocamara Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- 241001079007 Phellodendron chinense Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037597 Pyelonephritis acute Diseases 0.000 description 1
- 206010037601 Pyelonephritis chronic Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 244000299492 Thespesia populnea Species 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 208000025254 Vulval disease Diseases 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000001555 acute pyelonephritis Diseases 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000006368 chronic pyelonephritis Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000008273 gelatin Chemical class 0.000 description 1
- 229920000159 gelatin Chemical class 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 201000006669 vulvar dystrophy Diseases 0.000 description 1
- 208000002003 vulvitis Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗外阴瘙痒的中药组合物及其制备方法。该中药是由大叶桉、五色梅叶,大风艾、黄柏、扛板归等中药原料制备而成的。本发明还提供了这种中药组合物的制备方法。本发明提供的中药组合物主要用于治疗外阴瘙痒。
Description
技术领域
本发明涉及中药领域,具体涉及一种治疗外阴瘙痒的中药组合物及其制备方法。
背景技术
妇女外阴及阴道瘙痒,甚则痒痛难忍,坐卧不宁,或伴带下增多者,称为“阴痒”,亦称“阴门瘙痒”、“阴空格”。
本病相当于西医学外阴瘙痒症、外阴炎、阴道炎及外阴营养不良。
主要机理有虚、实两个方面。因肝肾阴虚,精血亏损,外阴失养而致阴痒,属虚证;因肝经湿热下注,带下浸渍阴部,或湿热生虫,虫蚀阴中以致阴痒,为实证。常见分型有肝肾阴虚、肝经湿热、湿虫滋生三型。
一、肝肾阴虚
素体阴虚,大病久病,或产多乳众,耗伤精血,以致肝肾阴虚。肝脉过阴器,肾司二阴,肝肾阴虚,精血不足,阴户失养,且血燥生风,风动则痒。
主要证候:阴部干涩,奇痒难忍,或阴部皮肤变白,增厚或萎缩,皲裂破溃,五心烦热,头晕目眩,时有烘热汗出,腰酸腿软,舌红,苔少,脉弦细而数。
治疗法则:调补肝肾,滋阴降火。
二、肝经湿热
郁怒伤肝,肝郁化热,肝气犯脾,脾虚湿盛,以致湿热互结,损伤任带,带下量多,浸渍阴部,而发痒痛。
主要证候:阴部瘙痒灼痛,带下量多,色黄如脓,稠粘臭秽,头晕目眩,口苦咽干,心烦不宁,便秘溲赤,舌红,苔黄腻,脉弦滑而数。
治疗法则:泻肝清热,除湿止痒。
三、湿虫滋生
素体脾虚湿盛,积久化热,流注下焦,损伤任带,湿热蕴积生虫,或外阴不洁,或久居阴湿之地,湿虫滋生,虫蚀阴中,都可导致阴痒。
主要证候:阴部瘙痒,如虫行状,甚则奇痒难忍,灼热疼痛,带下量多,色黄呈泡沫状,或色白如豆渣状,臭秽,心烦少寐,胸闷呃逆,口苦咽干,小便黄赤,舌红,苔黄腻,脉滑数。
治疗法则:清热利湿,解毒杀虫。
发明内容
本发明的目的是提供一种治疗外阴瘙痒的中药组合物;
本发明的另一目的是提供一种治疗外阴瘙痒的中药组合物的制备方法。
本发明的目的是通过下列的技术方案实现的:
本发明所述的治疗外阴瘙痒的中药组合物,是由如下重量份的中药原料制备而成的:
大叶桉20-40份、五色梅叶10-30份、大风艾8-25份、黄柏20-40份、扛板归10-30份。
优选地,是由如下重量份的中药原料制备而成的:
大叶桉25-35份、五色梅叶15-25份、大风艾10-20份、黄柏25-35份、扛板归15-25份。
以下是本发明中药制剂的药材来源:
大叶桉,为桃金娘科桉属植物大叶桉Eucalyptus robusta Smith,以叶入药。【性味】微辛、微苦,平。【功能主治】疏风解热,抑菌消炎,防腐止痒。用于预防流行性感冒、流行性脑脊髓膜炎,治上呼吸道感染,咽喉炎,支气管炎,肺炎,急、慢性肾盂肾炎,肠炎,痢疾,丝虫病;外用治烧烫伤,蜂窝织炎,乳腺炎,疖肿,丹毒,水田皮炎,皮肤湿疹,脚癣,皮肤消毒。
五色梅叶,为马鞭草科植物马樱丹的叶或嫩枝叶。【性味】味辛;苦;性凉;无毒。【功能主治】清热解毒;祛风止痒。主痈肿毒疮;湿疹;疥癣;皮炎;跌打损伤。
大风艾,为菊科艾纳香属植物大风艾Blumea balsamifera DC.,以根、嫩枝、叶入药。【性味】辛、微苦,微温。【功能主治】祛风消肿,活血散瘀。用于感冒,风湿性关节炎,产后风痛,痛经;外用治跌打损伤,疮疖痈肿,湿疹,皮炎。
黄柏,为芸香科植物黄皮树Phellodendron chinense Schneid.或黄檗Phellodendron amurense Rupr.的干燥树皮。【性味】苦,寒。【归经】归肾、膀胱经。【功能主治】清热燥湿,泻火除蒸,解毒疗疮。用于湿热泻痢,黄疸,带下,热淋,脚气,痿{辟},骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹瘙痒。盐黄柏滋阴降火。用于阴虚火旺,盗汗骨蒸。
扛板归,为蓼科植物扛板归的全草。【性味】酸苦,平。【功能主治】利水消肿,清热,活血,解毒。治水肿,黄疸,泄泻,疟疾,痢疾,百日咳,淋浊,丹毒,瘰疬,湿疹,疥癣。
本发明的另一方面是提供了本发明中药组合物的活性成分的制备方法,该方法是采用水提或40-80%体积百分浓度的乙醇提取制备而成。具体制备方法如下:
方案一:取全部药材,混合后加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为1-3小时,合并提取液,滤过,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,即得活性成分。
方案二:取全部药材,混合后用40-80%乙醇回流提取2-3次,每次乙醇用量为药材总量的4-10倍,提取时间为1-4小时,合并提取液,过滤,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,即得活性成分。
方案三:取全部药材,混合后加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为1-3小时,合并提取液,滤过,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,加入乙醇,使含醇量为40-70%,静置12-24小时,滤过,滤液浓缩至70-80℃时相对密度为1.10-1.25的浸膏,即得活性成分。
本发明所述的治疗外阴瘙痒的中药组合物,还可以与医药学上可接受的载体配合,制成各种口服制剂,如丸剂、片剂、胶囊剂、口服液、糖浆剂、合剂等。
本发明的药学上可接受的载体包括但不限于以下:
口服制剂:
稀释剂:淀粉、糖粉、乳糖、糊精、微晶纤维素、无机盐、糖醇类等。
润湿剂与粘合剂:纯化水、乙醇、明胶、聚乙二醇、纤维素衍生物等。
崩解剂:淀粉、羧甲基淀粉钠、纤维素衍生物、交联聚维酮等。
润滑剂:硬脂酸镁、微粉硅胶、滑石粉、聚乙二醇等。
助溶剂:水、乙醇、甘油、丙二醇、液状石蜡、植物油等。
矫味剂:蔗糖、单糖、芳香剂等。
防腐剂:苯甲酸、山梨酸、甲酯、乙酯、丙酯等。
方法1:片剂
取方案一至方案三所得活性成分之一,加入片剂常用辅料,按常规生产方法制备得本发明片剂。
上述片剂常用辅料包括稀释剂、润湿剂、粘合剂、崩解剂、润滑剂之一或全部。
方法2:胶囊剂
取方案一至方案三所得活性成分之一,加入胶囊剂常用辅料,按常规生产方法制备得本发明胶囊剂。
上述胶囊剂常用辅料包括稀释剂、润湿剂、粘合剂、崩解剂、润滑剂之一或全部。
方法3:糖浆剂
取方案一至方案三所得活性成分之一,加入糖浆剂常用辅料,按常规生产方法制备得本发明糖浆剂。
上述糖浆剂常用辅料包括矫味剂、防腐剂、助溶剂之一或全部。
方法4:合剂
取方案一至方案三所得活性成分之一,加入合剂常用辅料,按常规生产方法制备得本发明合剂。
上述合剂常用辅料包括矫味剂、防腐剂之一或全部。
方法5:口服液
取方案一至方案三所得活性成分之一,溶解后净化、浓缩,加入口服液常用辅料,按常规生产方法制备得本发明口服液。
本申请人在广泛阅读古今文献,运用传统中医理论,结合现代诊疗经验,找到一种治疗外阴瘙痒疾病的中药组合物。方中大叶桉疏风解热,抑菌消炎,防腐止痒、黄柏清热燥湿,为方中君药;五色梅叶清热解毒,祛风止痒、扛板归清热解毒而为臣;大风艾祛风而为佐。综观全方,全方相互配合,具有疏风止痒,抑菌消炎之功效。用于外阴瘙痒的治疗。
本发明提供的一种治疗外阴瘙痒的中药组合物具有以下优点:
1、本发明提供的组合物制剂安全有效, 具有疏风止痒,抑菌消炎之功效。用于外阴瘙痒的治疗。
2、本发明提供的中药组合物制剂,配方科学合理,工艺简单,口感好,成本低。
具体实施方式
下面通过实施例进一步说明本发明。应该理解的是,本发明的实施例是用于说明本发明而不是对本发明的限制。根据本发明的实质对本发明进行的简单改进都属于本发明要求保护的范围。除非另有说明,本发明中的乙醇量的百分数是体积百分数,v/v表示溶液的体积比。
实施例1 颗粒剂
称取大叶桉20g、五色梅叶10g、大风艾8g、黄柏20g、扛板归10g。加水提取3次,三次加水量分别为药材总重量的12倍、8倍、6倍,三次提取时间分别为3小时、2小时、1小时,合并提取液,滤过,滤液浓缩至70℃时相对密度为1.25的清膏,加入淀粉、糊精,制粒、干燥、整粒即得。
实施例2 片剂
称取大叶桉40g、五色梅叶30g、大风艾25g、黄柏40g、扛板归30g。用乙醇回流提取2次,每次乙醇浓度分别为80%、60%,每次乙醇用量分别为药材总量的10倍、8倍,提取时间分别为4小时、3小时,合并提取液,过滤,滤液浓缩至80℃时相对密度为1.10的浸膏,加入辅料淀粉、乙醇、滑石粉,制得片剂。
实施例3 片剂
称取大叶桉25g、五色梅叶15g、大风艾10g、黄柏25g、扛板归15g。加水提取3次,三次加水量分别相当于药材总重量的12倍、8倍、6倍,每次提取时间分别3小时、2小时、1小时,合并提取液,滤过,滤液浓缩至70℃时相对密度为1.20的清膏,加入乙醇,使含醇量为40%,静置24小时,滤过,滤液浓缩至滤液浓缩至70℃时相对密度为1.10的浸膏,加入辅料淀粉、乙醇、滑石粉,制得片剂。
实施例4 胶囊剂
称取大叶桉35g、五色梅叶25g、大风艾20g、黄柏35g、扛板归25g。用40%乙醇回流提取3次,每次乙醇用量分别为药材总量的10倍、8倍、4倍,提取时间分别3小时、2小时、1小时,合并提取液,过滤,滤液浓缩60℃时相对密度为1.25的浸膏,在浸膏中加入辅料淀粉、乙醇、糊精、硬脂酸镁,按常规方法制成胶囊剂。
实施例5 颗粒剂
称取大叶桉30g、五色梅叶20g、大风艾15g、黄柏30g、扛板归20g。加水提取2次,每次加水量分别相当于药材总重量的12倍、10倍,每次提取时间分别为3小时、2小时,合并提取液,滤过,滤液浓缩至80℃下相对密度为1.05的清膏,加入乙醇,使含醇量为70%,静置12小时,滤过,滤液浓缩至70℃时相对密度为1.25的浸膏,加入淀粉、糊精,制粒、干燥、整粒即得。
实施例6 糖浆剂
称取大叶桉23g、五色梅叶12g、大风艾9g、黄柏23g、扛板归12g。加水提取2次,两次加水量分别为药材总重量的10倍、8倍,两次提取时间分别为2小时、1小时,合并提取液,滤过,滤液浓缩至80℃时相对密度为1.10的浸膏。在浸膏中加入糖浆剂辅料蔗糖、山梨酸、水搅拌均匀,制得糖浆剂。
实施例7 口服液
称取大叶桉28g、五色梅叶18g、大风艾12g、黄柏28g、扛板归18g。加水提取2次,两次加水量分别为药材总重量的10倍、8倍,两次提取时间分别为2小时、1小时,合并提取液,滤过,滤液浓缩至80℃时相对密度为1.10的浸膏,在浸膏中加入辅料甘露醇、山梨酸、水搅拌均匀,分装,制得口服液。
实施例8 合剂
称取大叶桉32g、五色梅叶23g、大风艾18g、黄柏32g、扛板归23g。加水提取3次,三次加水量分别相当于药材总重量的12倍、8倍、6倍,每次提取时间分别3小时、2小时、1小时,合并提取液,滤过,滤液浓缩至总重量为药材总重量的3倍,灌装,加入合剂辅料蔗糖、乙酯、水、山梨酸搅拌均匀,制得合剂。
实施例9 粉剂
称取大叶桉38g、五色梅叶28g、大风艾23g、黄柏38g、扛板归28g。粉碎,过筛,即得。
典型病例
1、白X,女,19岁。 白带量多,外阴瘙痒6个月。患者自述从半年前开始出现白带量异常增多,有时一天要使用多条卫生巾,伴局部瘙痒,自觉难以忍受。曾经先后就诊于多家医院,确诊为“霉菌性阴道炎”,经西药口服、外用,仍反复难愈。给予本发明实施例2治疗,服药3天,白带量显著减少,且瘙痒症状缓解,一周药吃完后,未再见白带。继续用药调整3周,所有症状均缓解。随访两年,未见复发。
2、魏X,女,33岁。自述感觉外阴瘙痒,白带变多又呈灰白色,还会有气泡,更有一股腥臭味,白带检查:细菌性阴道炎。给予本发明实施例6治疗,7天后痊愈,巩固7天,随访一年未复发。
虽然,上文中已经用一般性说明、具体实施方式及试验,对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (7)
1.一种治疗外阴瘙痒的中药组合物,其特征在于它是由如下重量份的中药原料制备而成的:
大叶桉20-40份、五色梅叶10-30份、大风艾8-25份、黄柏20-40份、扛板归10-30份。
2.如权利要求1所述的治疗外阴瘙痒的中药组合物,其特征在于它是由包括如下重量份的中药原料制备而成的:大叶桉25-35份、五色梅叶15-25份、大风艾10-20份、黄柏25-35份、扛板归15-25份。
3.如权利要求1或2所述的治疗外阴瘙痒的中药组合物,其特征在于它的活性成分是采用水提或40-80%体积百分浓度的乙醇提取制备而成。
4.如权利要求3所述的治疗外阴瘙痒的中药组合物,其特征在于它的活性成分是通过以下方法制备而成的:取全部药材,混合后加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为1-3小时,合并提取液,滤过,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,即得活性成分。
5.如权利要求3所述的治疗外阴瘙痒的中药组合物,其特征在于它的活性成分是通过以下方法制备而成的:取全部药材,混合后用40-80%乙醇回流提取2-3次,每次乙醇用量为药材总量的4-10倍,提取时间为1-4小时,合并提取液,过滤,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,即得活性成分。
6.如权利要求3所述的治疗外阴瘙痒的中药组合物,其特征在于它的活性成分是通过以下方法制备而成的:取全部药材,混合后加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为1-3小时,合并提取液,滤过,滤液浓缩至70-80℃时相对密度为1.15-1.20的清膏,加入乙醇,使含醇量为40-70%,静置12-24小时,滤过,滤液浓缩至70-80℃时相对密度为1.10-1.25的浸膏,即得活性成分。
7.一种治疗外阴瘙痒的制剂,由权利要求1-6所述的治疗外阴瘙痒的中药组合物与医药学上可接受的载体配合制备而成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610944759.4A CN106421165A (zh) | 2016-11-02 | 2016-11-02 | 一种治疗外阴瘙痒的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610944759.4A CN106421165A (zh) | 2016-11-02 | 2016-11-02 | 一种治疗外阴瘙痒的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106421165A true CN106421165A (zh) | 2017-02-22 |
Family
ID=58179064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610944759.4A Withdrawn CN106421165A (zh) | 2016-11-02 | 2016-11-02 | 一种治疗外阴瘙痒的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106421165A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107737182A (zh) * | 2017-12-13 | 2018-02-27 | 柳州草子吉生物科技有限公司 | 一种治疗宫颈糜烂的中药组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102357168A (zh) * | 2011-10-10 | 2012-02-22 | 赵全成 | 一种治疗妇科疾病的中药组合物及其制备方法 |
-
2016
- 2016-11-02 CN CN201610944759.4A patent/CN106421165A/zh not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102357168A (zh) * | 2011-10-10 | 2012-02-22 | 赵全成 | 一种治疗妇科疾病的中药组合物及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107737182A (zh) * | 2017-12-13 | 2018-02-27 | 柳州草子吉生物科技有限公司 | 一种治疗宫颈糜烂的中药组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103690853B (zh) | 一种治疗湿烂型脚癣的中药制剂及其制备方法 | |
CN102106941B (zh) | 治疗痔疮的中药制剂及其制备方法 | |
CN104815192A (zh) | 一种治疗高血压的药物组合物及其应用 | |
CN101433655B (zh) | 一种治疗阴道炎的中药组合物 | |
CN104815037A (zh) | 一种治疗风湿蕴毒型慢性湿疹的药物及其制备方法 | |
CN106421165A (zh) | 一种治疗外阴瘙痒的中药组合物及其制备方法 | |
CN104001118A (zh) | 用于治疗湿热浸淫型运动神经元病的药物及其制备方法 | |
CN101199652B (zh) | 治疗急性、亚急性湿疹的药物及其制备方法 | |
CN103735695A (zh) | 一种治疗尿路感染的中药组合物及其制备方法 | |
CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN104324185A (zh) | 一种治疗白带过多的中药组合物及其制备方法 | |
CN104056234A (zh) | 一种解酒的药物及其制备方法 | |
KR101302658B1 (ko) | 소아야제 치료용 한약 조성물 및 이의 제조방법 | |
CN106389629A (zh) | 一种治疗湿疹身痒的中药组合物及其制备方法 | |
CN103479915B (zh) | 一种治疗急性肾炎的中药组合物及其制备方法 | |
CN101152294A (zh) | 一种中药软胶囊及其制备方法 | |
CN105396007A (zh) | 一种防治霉菌性阴道炎的妇科外用洗液 | |
CN105343688A (zh) | 一种治疗心肌梗塞的药物组合物及其应用 | |
CN104940777A (zh) | 一种治疗肝旺脾弱型经行泄泻的冲剂及其制备方法 | |
CN103083552B (zh) | 一种用于治疗神经性皮肤炎症的药丸 | |
CN104758509A (zh) | 一种治疗气郁痰滞型妊娠高血压的药物及其制备方法 | |
CN104138505A (zh) | 一种治疗新生儿肺热血瘀型脐炎的中药组合物及其制备方法 | |
CN104666663A (zh) | 一种治疗湿毒浸淫型水肿的药物及其制备方法 | |
CN107737158A (zh) | 一种治疗失眠的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170222 |
|
WW01 | Invention patent application withdrawn after publication |